(Reuters) - Cancer drugmaker Geron Corp said it would halt the study of its experimental drug, imetelstat, as a treatment for breast cancer and the drug was also unlikely to move forward in trials for advanced non-small cell lung cancer, causing the company's shares to shed nearly half their value.
via Reuters: Health News Read More Here..
No comments:
Post a Comment